– After the VA announced in March it would offer a highly anticipated ketamine-based medication for treatment-resistant depression, a Department of Veterans Affairs panel voted last week against widespread use, instead restricting the drug for pre-approved, case-by-case treatment.

Read More >

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search